CADL   $6.05  3.07% Market Closed After Close 6.15 1.65%

Candel Therapeutics Inc
Total Cash 21.45M
totalCashPerShare 0.669
EBITDA -34.66M
Total Debt 18.56M
quickRatio 1.533
currentRatio 1.624
Total Revenue
debtToEquity
Revenue/Share
ROA -0.52311003
ROE -4.80677
grossProfits
freeCashflow -18.40M
operatingCashflow -30.87M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 188.01M
forwardPE
floatShares 17.50M
sharesOutstanding 32.08M
sharesShort 1.59M
sharesShortPriorMonth 1.69M
dateShortInterest
sharesPercentSharesOut 0.05%
heldPercentInsiders 0.31%
heldPercentInstitutions 0.20%
Short Ratio help_outline 5.13%
shortPercentOfFloat 0.07%
impliedSharesOutstanding
bookValue -0.321
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -49.99M
trailingEps -1.70%
forwardEps -0.91%
enterpriseToEbitda -5.42
lastDividendValue
lastDividendDate
currentQuarterEstimate 1Q 2024
institutionsCount 68
lastUpdated Oct. 17, 2024, 12:10 a.m.